Gzell C - Search Results

1

Dodecafluoropentane Emulsion as a Radiosensitizer in Glioblastoma Multiforme.

Lickliter JD, Ruben J, Kichenadasse G, Jennens R, Gzell C, Mason RP, Zhou H, Becker J, Unger E, Stea B. Lickliter JD, et al. Among authors: gzell c. Cancer Res Commun. 2023 Aug 21;3(8):1607-1614. doi: 10.1158/2767-9764.CRC-22-0433. eCollection 2023 Aug. Cancer Res Commun. 2023. PMID: 37609003 Free PMC article.

2

Acetazolamide versus placebo for cerebral oedema requiring dexamethasone in recurrent and/or progressive high-grade glioma: phase II randomised placebo-controlled double-blind study.

Agar MR, Nowak AK, Hovey EJ, Barnes EH, Simes J, Vardy JL, Wheeler HR, Kong BY, Leonard R, Hall M, Tim E, Spyridopoulos D, Sim HW, Lwin Z, Dowling A, Harrup R, Jennens R, Kichenadasse G, Dunlop T, Gzell C, Koh ES. Agar MR, et al. Among authors: gzell c. BMJ Support Palliat Care. 2023 Sep;13(3):354-362. doi: 10.1136/spcare-2022-004119. Epub 2023 Feb 17. BMJ Support Palliat Care. 2023. PMID: 36807048 Clinical Trial.

3

Elderly patients aged 65-75 years with glioblastoma multiforme may benefit from long course radiation therapy with temozolomide.

Gzell C, Wheeler H, Guo L, Kastelan M, Back M. Gzell C, et al. J Neurooncol. 2014 Aug;119(1):187-96. doi: 10.1007/s11060-014-1472-8. Epub 2014 May 15. J Neurooncol. 2014. PMID: 24830984

4

Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant Therapy.

Harris G, Jayamanne D, Wheeler H, Gzell C, Kastelan M, Schembri G, Brazier D, Cook R, Parkinson J, Khasraw M, Louw S, Back M. Harris G, et al. Among authors: gzell c. Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):802-810. doi: 10.1016/j.ijrobp.2017.02.028. Epub 2017 Feb 21. Int J Radiat Oncol Biol Phys. 2017. PMID: 28602411

5

Employment following chemoradiotherapy in glioblastoma: a prospective case series.

Gzell C, Wheeler H, Guo L, Kastelan M, Back M. Gzell C, et al. J Cancer Surviv. 2014 Mar;8(1):108-13. doi: 10.1007/s11764-013-0311-9. Epub 2013 Nov 9. J Cancer Surviv. 2014. PMID: 24214496

6

Radiotherapy in Glioblastoma: the Past, the Present and the Future.

Gzell C, Back M, Wheeler H, Bailey D, Foote M. Gzell C, et al. Clin Oncol (R Coll Radiol). 2017 Jan;29(1):15-25. doi: 10.1016/j.clon.2016.09.015. Epub 2016 Oct 13. Clin Oncol (R Coll Radiol). 2017. PMID: 27743773 Review.

7

Small increases in enhancement on MRI may predict survival post radiotherapy in patients with glioblastoma.

Gzell CE, Wheeler HR, McCloud P, Kastelan M, Back M. Gzell CE, et al. J Neurooncol. 2016 May;128(1):67-74. doi: 10.1007/s11060-016-2074-4. Epub 2016 Feb 15. J Neurooncol. 2016. PMID: 26879084

8

Large volume re-irradiation with bevacizumab is a feasible salvage option for patients with refractory high-grade glioma.

Back M, Gzell CE, Kastelan M, Guo L, Wheeler HR. Back M, et al. Among authors: gzell ce. Neurooncol Pract. 2015 Mar;2(1):48-53. doi: 10.1093/nop/npu031. Epub 2014 Dec 15. Neurooncol Pract. 2015. PMID: 26034641 Free PMC article.

9

Radiation recall dermatitis after pre-sensitization with pegylated liposomal doxorubicin.

Gzell CE, Carroll SL, Suchowerska N, Beith J, Tan K, Scolyer RA. Gzell CE, et al. Cancer Invest. 2009 May;27(4):397-401. doi: 10.1080/07357900802392667. Cancer Invest. 2009. PMID: 19219651

10

Biopsy-proven brain metastases from prostate cancer: a series of four cases with review of the literature.

Gzell CE, Kench JG, Stockler MR, Hruby G. Gzell CE, et al. Int Urol Nephrol. 2013 Jun;45(3):735-42. doi: 10.1007/s11255-013-0462-7. Epub 2013 May 11. Int Urol Nephrol. 2013. PMID: 23666549 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page